22nd,2024
S1 “Host-Virus Interactions: Mechanisms and Implications”
Rafael Sanjuan (Universitat de Valencia (Spain))
Yuta Shirogane (Department of Molecular Virology, Tokyo Medical and Dental University (Japan))
Asuka Nanbo (Nagasaki Univ. (Japan))
Chikako Ono (Center for Infectious Disease Education and Research (CiDER), Osaka University (Japan), Research Institute for Microbial Diseases (RIMD), Osaka University (Japan), Center for Advanced Modalities and DDS (CAMaD), Osaka University (Japan))
Kanako Terakado Kimura (Laboratory of Medical Virology, Institute for Life and Medical Sciences, Kyoto University (Japan))
Review Talk 1
Martin Beer (Institute of Diagnostic Virology, Friedrich-Loeffler-Institut, Insel Riems, Germany (Germany))
S2 “Towards the “true” bacterial infection control”
Kotaro Kiga (Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases (Japan))
Hirotaka Hiyoshi (Institute of Tropical Medicine, Nagasaki University (Japan))
Takashi Nozawa (Dept. Microbiol., Grad Sch Med., Kyoto University (Japan))
Nozomu Obana (Institute of Medicine, University of Tsukuba (Japan))
Ken Cadwell (University of Pennsylvania (United States of America))
Review Talk 2
Jie ZHOU (The University of Hong Kong (Hong Kong))
S3 “New Perspectives on Virus Structures and Functions”
Shangfan Hu (Lab of Ultrastructural Virology, Institute for Frontier Life and Medical Sciences, Kyoto Univ (Japan), Lab of Ultrastructural Virology, Graduate School of Biostudies, Kyoto Univ. (Japan), CREST, Japan Science and Technology Agency (Japan), Department of Virology, Institute of Tropical Medicine, Nagasaki University (Japan))
Yukihiko Sugita (Laboratory of Ultrastructural Virology, Institute for Life and Medical Sciences, Kyoto University (Japan), Laboratory of Ultrastructural Virology, Graduate School of Biostudy, Kyoto University (Japan), Hakubi Center for Advanced Research, Kyoto University (Japan))
Ray Burton-Smith (Exploratory Research Center for Life and Living Systems (Japan))
David Bhella (MRC - University of Glasgow Centre for Virus Research (UK))
Peter Rosenthal (The Francis Crick Institute (UK))
S4 “NEXT International Research Network for Virology”
Sara Cherry (University of Pennsylvania (United States of America))
Kazuo Takayama (Center for iPS Cell Research and Application, Kyoto University (Japan))
Yoshimasa Takahashi (National Institute of Infectious Diseases (Japan))
Lisa Ng (A*STAR Infectious Diseases Labs (Singapore))
Hiromichi Matsugo (Laboratory of RNA Viruses, Department of Virus Research, Institute for Life and Medical Sciences, Kyoto University (Japan), Department of Mammalian Regulatory Network, Graduate School of Biostudies, Kyoto University (Japan))
Tateki Suzuki (Institute for Life and Medical Sciences, Kyoto University (Japan))
Review Talk 3
Osamu Takeuchi (Grad. Sch. Med., Kyoto Univ. (Japan))
S5 “Innate Immunity and Inflammation”
Nobuhiko Kayagaki (Genentech, Inc. (United States of America))
Andrea Ablasser (Ecole Polytechnique Fédérale de Lausanne (Switzerland))
Tomohiko Taguchi (Tohoku University (Japan))
Hiroyuki Oshiumi (Department of Immunology, Faculty of Life Sciences, Kumamoto University (Japan))
Keiko Yasuda (Department of Medical Chemistry Graduate School of Medicine, Kyoto University (Japan))
Fanchong Jian (Peking University (China), Changping Laboratory (China))
Review Talk 4
Masaru Kanekiyo (Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health (United States of America))
S6 “Toward the next generation of vaccines (AMED-SCARDA)”
Masaharu Iwasaki (Laboratory of Emerging Viral Diseases, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University (Japan), Center for Infectious Disease Education and Research, Osaka University (Japan), Center for Advanced Modalities and Drug Delivery System, Osaka University (Japan), RNA Frontier Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University (Japan))
Alessandro Pardini (Department of BioMedical Research, University of Bern, Bern, (Switzerland), Department of Rheumatology and Immunology, University Hospital Bern, Bern, (Switzerland), Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, (Switzerland))
Ming Te Yeh (Osaka University (Japan))
Shuntaro Shimizu (Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo (IMSUT), Tokyo, Japan (Japan), International Vaccine Design Center, IMSUT, Tokyo, Japan (Japan), The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Japan (Japan), Department of Chemistry, Chemical Engineering & Life Science, Yokohama National University, Kanagawa, Japan (Japan))
Masayuki Kuraoka (Duke University (United States of America))
Hidetaka Akita (Graduate School of Pharmaceutical Sciences, Tokoku University (Japan), Center for Advanced Modalities and DDS, Osaka University (Japan))